Inhibition of PTEN activity aggravates cisplatin-induced acute kidney injury

Cisplatin (cis-Diamminedichloroplatinum II) has been widely and effectively used in chemotherapy against tumors. Nephrotoxicity due to cisplatin is one of the most common clinical causes of acute kidney injury (AKI), which has a poor prognosis and high mortality. The signaling mechanisms underlying...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jun, Fan, Youling, Tang, Simin, Wu, Huiping, Zhong, Jiying, Huang, Zhengxing, Yang, Chengxiang, Chen, Hongtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732719/
https://www.ncbi.nlm.nih.gov/pubmed/29262553
http://dx.doi.org/10.18632/oncotarget.20790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732719/
https://www.ncbi.nlm.nih.gov/pubmed/29262553
http://dx.doi.org/10.18632/oncotarget.20790

Ejemplares similares